litlas
ログインアカウント作成

Xuemei Li

2003–2026 年に発表

552
論文数
33,827
被引用数
86
h 指数
385
i10 指数

被引用数

Xuemei Li の年別被引用数1986 年: 被引用 1 件2001 年: 被引用 1 件2003 年: 被引用 15 件2004 年: 被引用 16 件2005 年: 被引用 29 件2006 年: 被引用 52 件2007 年: 被引用 43 件2008 年: 被引用 77 件2009 年: 被引用 108 件2010 年: 被引用 120 件2011 年: 被引用 118 件2012 年: 被引用 157 件2013 年: 被引用 140 件2014 年: 被引用 183 件2015 年: 被引用 187 件2016 年: 被引用 165 件2017 年: 被引用 226 件2018 年: 被引用 336 件2019 年: 被引用 841 件2020 年: 被引用 1,325 件2021 年: 被引用 1,559 件2022 年: 被引用 1,363 件2023 年: 被引用 1,155 件2024 年: 被引用 1,620 件2025 年: 被引用 991 件2026 年: 被引用 122 件2027 年: 被引用 1 件1987〜2000 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 4,731 件、この内訳の 31%アメリカ合衆国: 引用元論文 2,509 件、この内訳の 16.4%イギリス: 引用元論文 665 件、この内訳の 4.4%ドイツ: 引用元論文 498 件、この内訳の 3.3%インド: 引用元論文 457 件、この内訳の 3%イタリア: 引用元論文 434 件、この内訳の 2.8%フランス: 引用元論文 387 件、この内訳の 2.5%カナダ: 引用元論文 374 件、この内訳の 2.5%オーストラリア: 引用元論文 356 件、この内訳の 2.3%日本: 引用元論文 352 件、この内訳の 2.3%韓国: 引用元論文 311 件、この内訳の 2%スペイン: 引用元論文 305 件、この内訳の 2%
0%31%その他 25.5%

機関

分野

  • Medicine44.8%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Computer Science6.9%
  • Engineering6.1%
  • Decision Sciences3.6%
  • Materials Science3.4%
  • その他17.1%

トピック

  • Cancer Immunotherapy and Biomarkers3.4%
  • Ferroptosis and cancer prognosis3.3%
  • SARS-CoV-2 and COVID-19 Research2.1%
  • COVID-19 Clinical Research Studies1.8%
  • RNA modifications and cancer1.7%
  • Lung Cancer Treatments and Mutations1.4%
  • その他86.3%

共著者

全論文

検索で開く
  1. Identification of ACSL4 as a biomarker and contributor of ferroptosis

    著者: Hua Yuan, Xuemei Li, Xiuying Zhang, Rui Kang, Daolin Tang - Biochemical and Biophysical Research Communications 2016 被引用: 1,064

  2. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation

    著者: Hua Yuan, Xuemei Li, Xiuying Zhang, Rui Kang, Daolin Tang - Biochemical and Biophysical Research Communications 2016 被引用: 512

  3. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

    著者: Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi, Ben Creelan, Francisco Sánchez-Vega, Arun Ahuja, Ai Ni, Jacki B. Novik, Levi Mangarin, Mohsen Abu-Akeel, Cailian Liu, Jennifer L. Sauter, Natasha Rekhtman, Eliza Chang, Margaret K. Callahan, Jamie E. Chaft, Martin H. Voss, Megan Tenet, Xuemei Li, Kelly L. Covello, Andrea Renninger, Patrik Vitazka, William J. Geese, Hossein Borghaei, Charles M. Rudin, Scott Antonia, Charles Swanton, Jeff Hammerbacher, Taha Merghoub, Nicholas McGranahan, Alexandra Snyder, Jedd D. Wolchok - Cancer Cell 2018 被引用: 1,175

  4. Dynamic regulation and functions of mRNA m6A modification

    著者: Shanshan Wang, Wei Lv, Tao Li, Shubing Zhang, Huihui Wang, Xuemei Li, Lianzi Wang, Dongyue Ma, Yan Zang, Jilong Shen, Yuanhong Xu, Wei Wei - Cancer Cell International 2022 被引用: 222

  5. First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

    著者: Neal Ready, Matthew D. Hellmann, Mark M. Awad, Gregory A. Otterson, Martin Gutierrez, Justin F. Gainor, Hossein Borghaei, Jacques Jolivet, Leora Horn, Mihaela Mates, Julie R. Brahmer, Ian Rabinowitz, Pavan S. Reddy, Jason Chesney, James Michael Orcutt, David R. Spigel, Martin Reck, Kenneth J. O’Byrne, Luis Paz‐Ares, Wenhua Hu, Kim E. Zerba, Xuemei Li, Brian Lestini, William J. Geese, Joseph D. Szustakowski, George Green, Chang Han, Suresh S. Ramalingam - Journal of Clinical Oncology 2019 被引用: 596

  6. Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

    著者: Nan Chen, Chuan‐Ming Hao, Bi‐Cheng Liu, Hongli Lin, Caili Wang, Changying Xing, Xinling Liang, Gengru Jiang, Zhengrong Liu, Xuemei Li, Li Zuo, Laimin Luo, Jianqin Wang, Minghui Zhao, Zhihong Liu, Guangyan Cai, Hao Li, Robert Leong, Chunrong Wang, Cameron Liu, Thomas B. Neff, Lynda A. Szczech, Kin-Hung P. Yu - New England Journal of Medicine 2019 被引用: 613

  7. A stock price prediction method based on meta-learning and variational mode decomposition

    著者: Tengteng Liu, Xiang Ma, Shuo Li, Xuemei Li, Caiming Zhang - Knowledge-Based Systems, Knowl. Based Syst. 2022 被引用: 108

  8. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

    著者: Matthew D. Hellmann, Naiyer A. Rizvi, Jonathan W. Goldman, Scott Gettinger, Hossein Borghaei, Julie R. Brahmer, Neal Ready, David E. Gerber, Laura Q.M. Chow, Rosalyn A. Juergens, Frances A. Shepherd, Scott A. Laurie, William J. Geese, Shruti Agrawal, Tina C. Young, Xuemei Li, Scott Antonia - The Lancet Oncology 2016 被引用: 961

  9. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    著者: Xinyu Zhou, Teng Teng, Yuqing Zhang, Cinzia Del Giovane, Toshi A. Furukawa, John R. Weisz, Xuemei Li, Pim Cuijpers, David Coghill, Yajie Xiang, Sarah Hetrick, Stefan Leucht, Mengchang Qin, Jürgen Barth, Arun Ravindran, Lining Yang, John F. Curry, Li Fan, Susan G. Silva, Andrea Cipriani, Peng Xie - The Lancet Psychiatry 2020 被引用: 351

  10. Stock ranking prediction using a graph aggregation network based on stock price and stock relationship information

    著者: Guowei Song, Tianlong Zhao, Suwei Wang, Hua Wang, Xuemei Li - Information Sciences, Inf. Sci. 2023 被引用: 53

  11. Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD+ to alleviate mitochondrial disease

    著者: Shanshan Liu, Song Fu, Guodong Wang, Yu Cao, Lanlan Li, Xuemei Li, Jun Yang, Ning Li, Yabing Shan, Yang Cao, Yan Ma, Meng‐Qiu Dong, Qinghua Liu, Hui Jiang - Cell Metabolism 2021 被引用: 136

  12. Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome

    著者: Yuanchen Dong, Shuwen Zhang, Zhaolong Wu, Xuemei Li, Wei Li Wang, Yanan Zhu, Svetla Stoilova‐McPhie, Ying Lu, Daniel Finley, Youdong Mao - Nature 2018 被引用: 358

  13. A Review of Internet of Things - Resource Allocation

    著者: Xuemei Li, Li Da Xu - IEEE Internet of Things Journal, IEEE Internet Things J. 2020 被引用: 135

  14. Fuzzy hypergraph network for recommending top-K profitable stocks

    著者: Xiang Ma, Tianlong Zhao, Qiang Guo, Xuemei Li, Caiming Zhang - Information Sciences, Inf. Sci. 2022 被引用: 52

  15. Stretchable and Highly Sensitive Optical Strain Sensors for Human-Activity Monitoring and Healthcare

    著者: Jingjing Guo, Bingqian Zhou, Rui Zong, Longsheng Pan, Xuemei Li, Xinguang Yu, Changxi Yang, Lingjie Kong, Qionghai Dai - ACS Applied Materials & Interfaces 2019 被引用: 173

  16. A novel data-driven seasonal multivariable grey model for seasonal time series forecasting

    著者: Xuemei Li, Na Li, Song Ding, Yun Cao, Yao Li - Information Sciences, Inf. Sci. 2023 被引用: 50

  17. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

    著者: Yan Zhao, Ling Qin, Ping Zhang, Kang Li, Lianchun Liang, Jianping Sun, Bin Xu, Yanchao Dai, Xuemei Li, Chi Zhang, Yanchun Peng, Yingmei Feng, Ang Li, Zhongjie Hu, Haiping Xiang, Graham S. Ogg, Ling‐Pei Ho, Andrew J. McMichael, Ronghua Jin, Julian C. Knight, Tao Dong, Yonghong Zhang - JCI Insight 2020 被引用: 435

  18. Structural basis for enzymatic photocatalysis in chlorophyll biosynthesis

    著者: Shaowei Zhang, Derren J. Heyes, Lingling Feng, Wenli Sun, Linus O. Johannissen, Huanting Liu, Colin Levy, Xuemei Li, Ji Yang, Xiaolan Yu, Min Lin, Samantha J. O. Hardman, Robin Hoeven, Michiyo Sakuma, Sam Hay, David Leys, Zihe Rao, Aiwu Zhou, Qi Cheng, Nigel S. Scrutton - Nature 2019 被引用: 161

  19. Biomarkers of intestinal permeability and blood-brain barrier permeability in adolescents with major depressive disorder

    著者: Hongyan Wu, Jie Wang, Teng Teng, Bangmin Yin, Yuqian He, Yuanliang Jiang, Xueer Liu, Ying Yu, Xuemei Li, Xinyu Zhou - Journal of Affective Disorders 2022 被引用: 67

  20. The genetic sequence, origin, and diagnosis of SARS-CoV-2

    著者: Huihui Wang, Xuemei Li, Tao Li, Shubing Zhang, Lianzi Wang, Xian Wu, Jiaqing Liu - European Journal of Clinical Microbiology & Infectious Diseases 2020 被引用: 506

  21. Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC

    著者: Scott Gettinger, Matthew D. Hellmann, Laura Q.M. Chow, Hossein Borghaei, Scott Antonia, Julie R. Brahmer, Jonathan W. Goldman, David E. Gerber, Rosalyn A. Juergens, Frances A. Shepherd, Scott A. Laurie, Tina C. Young, Xuemei Li, William J. Geese, Naiyer A. Rizvi - Journal of Thoracic Oncology 2018 被引用: 179

  22. The adherence and colonization of microorganisms in fish gastrointestinal tract

    著者: Xuemei Li, Einar Ringø, Seyed Hossein Hoseinifar, Hélène L. Lauzon, Harry Birkbeck, Deguo Yang - Reviews in Aquaculture 2018 被引用: 158

  23. TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR

    著者: Tao Zhang, Bofang Wang, Fei Su, Baohong Gu, Lin Xiang, Lei Gao, Peng Zheng, Xuemei Li, Hao Chen - International Journal of Biological Sciences 2022 被引用: 98

  24. Multi-scale convolution enhanced transformer for multivariate long-term time series forecasting

    著者: Ao Li, Ying Li, Yunyang Xu, Xuemei Li, Caiming Zhang, Xuemei Li, Caiming Zhang - Neural Networks 2024 被引用: 45